News

Developed by Genentech and Novartis, Lucentis is an antibody fragment that is injected into the eye and acts by neutralizing VEGF. The EC’s approval was given on the

In addition to being an investigational pan-BCR-ABL inhibitor for use in chronic myeloid leukemia (CML), ponatinib inhibits certain other tyrosine kinases, including a specific mutation of FLT3 called

The double-blind, placebo-controlled study is designed to measure the efficacy, safety and tolerability of STX209, an oral selective gamma-amino butyric acid type B (GABA-B) receptor agonist. GABA-B receptors

Under the agreement, Biowa will receive the right to certain antibody technology from IMUC and selected option rights to IMUC antibodies using the POTELLIGENT Technology. POTELLIGENT Technology involves

PAT-LM1 is a natural human antibody that has been shown to have anti-cancer properties, in multiple animal models, including a potent effect in models of pancreatic, lung and

The capsules are the generic version of Wyeth’s Effexor XR capsules, which are used in the treatment of major depressive disorder and social anxiety disorder. Mylan is launching

Pfizer and Zhejiang Hisun Pharmaceuticals will explore a potential business collaboration focused on manufacturing cooperation to deliver and commercialize medicines through a local and global sales and marketing

Confab is a Montreal-based pharmaceutical manufacturing company with licenses from both FDA and European regulatory bodies, as well as certain Asian countries to manufacture drugs for human use.

XBiotech’s True Human monoclonal antibody, which blocks pathologic inflammatory responses, is being developed to treat diseases such as cancer, atherosclerosis and diabetes. C3i provides a solution to meet